Is XRAY Stock Undervalued?
Dentsply Sirona (NASDAQ:XRAY) is a large manufacturer of dental equipment…
Buy
68
ALNY Quote, Financials, Valuation and Earnings
Last price:
$450.88
Seasonality move
:
6.76%
Day range:
$444.79 - $453.96
52-week range:
$205.87 - $469.81
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
23.49x
P/B ratio:
233.56x
Volume:
827.6K
Avg. volume:
1.2M
1-year change:
55.57%
Market cap:
$58.5B
Revenue:
$2.2B
EPS (TTM):
-$2.47
Earnings Data
Next earnings date for ALNY
Oct 30
2025
Most recent earnings per share
-$0.51
Missed by $0.66
(Jul 31/2025)
Consensus Estimate
$0.15
(Jul 31/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ALNY Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 10/30/2025 | Q3 | $942.7M | -- | -- | $1.44 | -- |
| 07/31/2025 | Q2 | $662.5M | $773.7M | -$0.51 | $0.15 | -$0.66 |
| 05/01/2025 | Q1 | $581.2M | $594.2M | -$0.44 | -$0.37 | -$0.07 |
| 02/13/2025 | Q4 | $580.6M | $593.2M | -$0.65 | -$0.14 | -$0.51 |
| 10/31/2024 | Q3 | $527M | $500.9M | -$0.87 | -$0.39 | -$0.48 |
| 08/01/2024 | Q2 | $444.2M | $659.8M | -$0.13 | -$0.69 | $0.56 |
| 05/02/2024 | Q1 | $426.7M | $494.3M | -$0.52 | -$0.63 | $0.11 |
| 02/15/2024 | Q4 | $442.3M | $439.7M | -$1.10 | -$0.77 | -$0.33 |
| 11/02/2023 | Q3 | -- | -- | $1.15 | -$0.96 | $2.11 |
| 08/03/2023 | Q2 | -- | -- | -$2.21 | -$1.34 | -$0.87 |
| 05/04/2023 | Q1 | -- | -- | -$1.40 | -$1.43 | $0.03 |
| 02/23/2023 | Q4 | -- | -- | -$1.68 | -$1.48 | -$0.20 |
| 10/27/2022 | Q3 | -- | -- | -$3.32 | -$1.38 | -$1.94 |
| 07/28/2022 | Q2 | -- | -- | -$2.29 | -$1.36 | -$0.93 |
| 04/28/2022 | Q1 | -- | -- | -$2.00 | -$1.46 | -$0.54 |
| 02/10/2022 | Q4 | -- | -- | -$2.16 | -$1.26 | -$0.90 |
| 10/28/2021 | Q3 | -- | -- | -$1.72 | -$1.24 | -$0.48 |
| 08/03/2021 | Q2 | -- | -- | -$1.61 | -$1.28 | -$0.33 |
| 04/29/2021 | Q1 | -- | -- | -$1.71 | -$1.40 | -$0.31 |
| 02/11/2021 | Q4 | -- | -- | -$2.09 | -$1.38 | -$0.71 |
| 11/05/2020 | Q3 | -- | -- | -$2.18 | -$1.34 | -$0.84 |
| 08/06/2020 | Q2 | -- | -- | -$1.56 | -$1.40 | -$0.16 |
| 05/06/2020 | Q1 | -- | -- | -$1.62 | -$1.51 | -$0.11 |
| 02/06/2020 | Q4 | -- | -- | -$2.47 | -$1.92 | -$0.55 |
| 10/31/2019 | Q3 | -- | -- | -$1.92 | -$1.83 | -$0.09 |
| 08/06/2019 | Q2 | -- | -- | -$1.83 | -$1.85 | $0.02 |
| 05/01/2019 | Q1 | -- | -- | -$1.42 | -$1.80 | $0.38 |
| 02/07/2019 | Q4 | -- | -- | -$1.82 | -$1.93 | $0.11 |
| 11/07/2018 | Q3 | -- | -- | -$1.56 | -$1.79 | $0.23 |
| 08/02/2018 | Q2 | -- | -- | -$1.83 | -$1.71 | -$0.12 |
| 05/03/2018 | Q1 | -- | -- | -$1.41 | -$1.51 | $0.10 |
| 02/08/2018 | Q4 | -- | -- | -$1.48 | -$1.36 | -$0.12 |
| 11/07/2017 | Q3 | -- | -- | -$1.34 | -$1.23 | -$0.11 |
| 08/09/2017 | Q2 | -- | -- | -$1.34 | -$1.17 | -$0.17 |
| 05/05/2017 | Q1 | -- | -- | -$1.25 | -$1.24 | -$0.01 |
| 02/08/2017 | Q4 | -- | -- | -$1.32 | -$1.31 | -$0.01 |
| 11/02/2016 | Q3 | -- | -- | -- | -- | -- |
| 08/04/2016 | Q2 | -- | -- | -- | -- | -- |
| 05/02/2016 | Q1 | -- | -- | -- | -- | -- |
| 02/11/2016 | Q4 | -- | -- | -- | -- | -- |
| 11/09/2015 | Q3 | -- | -- | -- | -- | -- |
Alnylam Pharmaceuticals, Inc. Earnings Questions
-
How Much did Alnylam Pharmaceuticals, Inc. Generate in Revenue Last Quarter?
Alnylam Pharmaceuticals, Inc. reported $773.7M worth of top line sales in its most recent quarter.
-
Did Alnylam Pharmaceuticals, Inc. Beat Earnings Last Quarter?
Alnylam Pharmaceuticals, Inc. announced earnings per share of -$0.51 which represents a miss of analyst forecast a $0.15 per share.
-
Is Alnylam Pharmaceuticals, Inc. Profitable?
Alnylam Pharmaceuticals, Inc. reported $630.7M that represents $4.83 per share over the last quarter.
-
What is the Analyst Consensus for Alnylam Pharmaceuticals, Inc. EPS Next Year?
Alnylam Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$2.18 per share to -$0.24 per share next year representing a decrease of -93.04%.
-
When is Alnylam Pharmaceuticals, Inc.'s Earnings Date?
Alnylam Pharmaceuticals, Inc.'s next earnings date is October 30, 2025.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Clarivate Stock Undervalued?
Clarivate (NYSE:CLVT) is an analytics and research business whose services…
Is Dick’s Sporting Goods Stock Undervalued?
The market still prices Dick’s Sporting Goods (NYSE: DKS) at…
Stock Ideas
Buy
61
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 37x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 38x
Alerts
Sell
30
MRVL alert for Sep 2
Marvell Technology, Inc. [MRVL] is down 0.36% over the past day.
Buy
62
ZEPP alert for Sep 2
Zepp Health Corp. [ZEPP] is down 1.2% over the past day.
Buy
78
AMBA alert for Sep 2
Ambarella, Inc. [AMBA] is down 7.26% over the past day.
